Merit Medical Systems Inc MMSI
We take great care to ensure that the data presented and summarized in this overview for MERIT MEDICAL SYSTEMS INC is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding MMSI
View all-
Black Rock Inc. New York, NY8.91MShares$924 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.65MShares$689 Million0.01% of portfolio
-
State Street Corp Boston, MA2.29MShares$238 Million0.01% of portfolio
-
Conestoga Capital Advisors, LLC2.29MShares$237 Million2.96% of portfolio
-
Fuller & Thaler Asset Management, Inc. San Mateo, CA1.63MShares$169 Million0.61% of portfolio
-
Invesco Ltd. Atlanta, GA1.54MShares$159 Million0.03% of portfolio
-
Macquarie Group LTD Australia, C31.45MShares$150 Million0.16% of portfolio
-
Geode Capital Management, LLC Boston, MA1.36MShares$141 Million0.01% of portfolio
-
Arrow Mark Colorado Holdings LLC Denver, CO1.27MShares$132 Million1.85% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.18MShares$123 Million0.03% of portfolio
Latest Institutional Activity in MMSI
Top Purchases
Top Sells
About MMSI
Merit Medical Systems, Inc. designs, develops, manufactures, and markets single-use medical products for interventional, diagnostic, and therapeutic procedures, primarily in cardiology, radiology, oncology, critical care, and endoscopy. The company operates in two segments, Cardiovascular and Endoscopy. It provides peripheral intervention products for the diagnosis and treatment of diseases in peripheral vessels and organs; and cardiac intervention products, such as access, angiography, electrophysiology and cardiac rhythm management, fluid management, hemodynamic monitoring, hemostasis, and intervention to treat various heart conditions. The company also offers custom procedural solutions that include critical care products, disinfection protection systems, syringes, manifold kits, and trays and packs; coated tubes and wires; and sensor components for microelectromechanical systems. In addition, it provides pulmonary products that consist of laser-cut tracheobronchial stents, over-the-wire and direct visualization delivery systems, and dilation balloons to endoscopically dilate strictures; gastroenterology products; and kits and accessories for endoscopy and bronchoscopy procedures. The company sells its products to hospitals and alternate site-based physicians, technicians, and nurses through direct sales force, distributors, original equipment manufacturer partners, or custom procedure tray manufacturers in the United States and internationally. Merit Medical Systems, Inc. was incorporated in 1987 and is headquartered in South Jordan, Utah.
Insider Transactions at MMSI
Insider Transaction List
View allDate | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Mar 13
2025
|
Brian G. Lloyd CHIEF LEGAL OFFICER, SECRETARY |
SELL
Bona fide gift
|
Direct |
4,700
-12.07%
|
-
|
Mar 05
2025
|
Fred P Lampropoulos President and CEO |
SELL
Open market or private sale
|
Indirect |
2,999
-14.45%
|
$308,897
$103.75 P/Share
|
Mar 05
2025
|
Fred P Lampropoulos President and CEO |
SELL
Open market or private sale
|
Direct |
31,320
-1.41%
|
$3,225,960
$103.9 P/Share
|
Mar 05
2025
|
Brian G. Lloyd CHIEF LEGAL OFFICER, SECRETARY |
SELL
Open market or private sale
|
Direct |
30,000
-43.51%
|
$3,060,000
$102.9 P/Share
|
Mar 05
2025
|
Brian G. Lloyd CHIEF LEGAL OFFICER, SECRETARY |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+30.32%
|
$1,650,000
$55.73 P/Share
|
Mar 05
2025
|
Raul Parra Jr. CFO AND TREASURER |
SELL
Open market or private sale
|
Direct |
5,361
-18.13%
|
$552,183
$103.58 P/Share
|
Mar 05
2025
|
Raul Parra Jr. CFO AND TREASURER |
BUY
Exercise of conversion of derivative security
|
Direct |
5,361
+15.35%
|
$198,357
$37.71 P/Share
|
Mar 04
2025
|
Michel James Voigt CHIEF HUMAN RESOURCES OFFICER |
SELL
Bona fide gift
|
Direct |
620
-2.77%
|
-
|
Mar 04
2025
|
Brian G. Lloyd CHIEF LEGAL OFFICER, SECRETARY |
SELL
Bona fide gift
|
Direct |
48
-0.12%
|
-
|
Mar 03
2025
|
Stephen C. Evans |
SELL
Open market or private sale
|
Direct |
5,000
-51.78%
|
$525,000
$105.31 P/Share
|
Mar 03
2025
|
Neil Peterson CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
5,000
-14.98%
|
$525,000
$105.0 P/Share
|
Mar 03
2025
|
Neil Peterson CHIEF OPERATING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+13.03%
|
$270,000
$54.4 P/Share
|
Feb 28
2025
|
Brian G. Lloyd CHIEF LEGAL OFFICER, SECRETARY |
SELL
Open market or private sale
|
Direct |
25,000
-39.07%
|
$2,475,000
$99.5 P/Share
|
Feb 28
2025
|
Brian G. Lloyd CHIEF LEGAL OFFICER, SECRETARY |
BUY
Exercise of conversion of derivative security
|
Direct |
25,000
+28.09%
|
$1,100,000
$44.8 P/Share
|
Feb 28
2025
|
Brian G. Lloyd CHIEF LEGAL OFFICER, SECRETARY |
BUY
Grant, award, or other acquisition
|
Direct |
7,056
+15.32%
|
-
|
Feb 28
2025
|
Neil Peterson CHIEF OPERATING OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
6,272
+18.11%
|
-
|
Feb 28
2025
|
Raul Parra Jr. CFO AND TREASURER |
SELL
Open market or private sale
|
Direct |
12,451
-33.97%
|
$1,220,198
$98.81 P/Share
|
Feb 28
2025
|
Raul Parra Jr. CFO AND TREASURER |
BUY
Grant, award, or other acquisition
|
Direct |
7,840
+17.62%
|
-
|
Feb 28
2025
|
Michel James Voigt CHIEF HUMAN RESOURCES OFFICER |
SELL
Open market or private sale
|
Direct |
13,809
-38.14%
|
$1,367,091
$99.68 P/Share
|
Feb 28
2025
|
Michel James Voigt CHIEF HUMAN RESOURCES OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
13,809
+12.28%
|
$869,967
$63.95 P/Share
|
Last 12 Months Summary
Grant, award, or other acquisition | 155K shares |
---|---|
Exercise of conversion of derivative security | 223K shares |
Payment of exercise price or tax liability | 76.1K shares |
---|---|
Open market or private sale | 203K shares |
Bona fide gift | 5.37K shares |